Literature DB >> 15695498

Inequity of use of implantable cardioverter defibrillators in England: retrospective analysis.

Julie Parkes1, Deborah L Chase, Andrew Grace, David Cunningham, Paul J Roderick.   

Abstract

Mesh:

Year:  2005        PMID: 15695498      PMCID: PMC549656          DOI: 10.1136/bmj.38337.635648.82

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

2.  Variations in use of cardiology services in a health authority: comparison of coronary artery revascularisation rates with prevalence of angina and coronary mortality.

Authors:  N Payne; C Saul
Journal:  BMJ       Date:  1997-01-25

3.  Addressing the inverse care law in cardiac services.

Authors:  Sue Langham; Ian Basnett; Peter McCartney; Charles Normand; Julie Pickering; Dilwyn Sheers; Margaret Thorogood
Journal:  J Public Health Med       Date:  2003-09

Review 4.  Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials.

Authors:  Justin A Ezekowitz; Paul W Armstrong; Finlay A McAlister
Journal:  Ann Intern Med       Date:  2003-03-18       Impact factor: 25.391

  4 in total
  2 in total

1.  [Quality improvement in Germany: a way to better electrophysiology?].

Authors:  C W Israel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2010-09

2.  Patient barriers to implantable cardioverter defibrillator implantation for the primary prevention of sudden cardiac death in patients with heart failure and reduced ejection fraction.

Authors:  Laura Lihua Chan; Choon Pin Lim; Soe Tin Aung; Paul Quetua; Kah Leng Ho; Daniel Chong; Wee Siong Teo; David Sim; Chi Keong Ching
Journal:  Singapore Med J       Date:  2016-04       Impact factor: 1.858

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.